BD Diagnostics and Lab21 are to collaborate to develop oncology assays for the BD MAX fully automated bench-top molecular system. Under the terms of the collaboration, Lab21 will develop polymerase chain reaction-based assays on the BD MAX platform for a series of oncology markers, while BD will be responsible for manufacturing and commercialising the tests worldwide.
Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers. We employ over 1,000 people, with sales and service subsidiaries in eight countries and distributors in more than 90 additional countries. Nova has manufacturing facilities in Waltham and Billerica, Massachusetts, Belo Horizonte, Brazil and in Taipei,...
Stockholmsmässan, Stockholm, Sweden
12-16 September, 2026
UKHSA, 61 Colindale Avenue, London NW9 5EQ
18 September, 2026
Manchester Central, Manchester, M2 3GX
22-23 September, 2026
Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow, G1 1RD
24-25 September, 2026
Hilton Antwerp Old Town, Antwerp
4-7 October, 2026
